Investing.com - Merck ADR reported on Friday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Merck ADR announced earnings per share of €0.5392 on revenue of €5.69B. Analysts polled by Investing.com EPS of €0.5165 on revenue of €5.57B.
Merck ADR 's are down 32.63% and is trading at €35.100 , still down 32.87% from its 52 week high of €52.29 set on Friday, December 31, 2021.
Merck ADR follows other major Healthcare sector earnings this month
Merck ADR's report follows an earnings beat by Medtronic on Tuesday, August 23, 2022, who reported EPS of €1.13 on revenue of €7.37B, EPS of €1.12 on revenue of €7.22B.
Agilent Technologies had beat expectations on Tuesday, August 16, 2022 with third quarter EPS of €1.34 on revenue of €1.72B, for EPS of €1.2 on revenue of €1.64B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar